TGFB1 and breast cancer: On the other hand, it has been demonstrated that induction of CDH5 during EMT promotes breast cancer progression via TGFβ signaling indicating that in certain tumor cells, CDH5 can induce cellular responses that are in contrast to its role in cell-cell contact growth inhibition in endothelial cells (Labelle et al., 2008).